Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children
Claudia Pasqualini
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorVeronique Minard-Colin
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorVeronique Saada
Department of Cytopathology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorLaurence Lamant
Department of Pathology, CHU Toulouse, Hôpital Purpan, Toulouse, France
INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France
Search for more papers by this authorGeorges Delsol
Department of Pathology, CHU Toulouse, Hôpital Purpan, Toulouse, France
INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France
Search for more papers by this authorCatherine Patte
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorMarie-Cécile Le Deley
Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France
Univ Paris-Sud, Le Kremlin-Bicêtre, France
Search for more papers by this authorDominique Valteau-Couanet
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorCorresponding Author
Laurence Brugières
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Correspondence: Dr Laurence Brugières, Department of Paediatric Oncology, Institut Gustave Roussy, 114 Rue Edouard-Vaillant, 94805 Villejuif Cedex, France.
E-mail: [email protected]
Search for more papers by this authorClaudia Pasqualini
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorVeronique Minard-Colin
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorVeronique Saada
Department of Cytopathology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorLaurence Lamant
Department of Pathology, CHU Toulouse, Hôpital Purpan, Toulouse, France
INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France
Search for more papers by this authorGeorges Delsol
Department of Pathology, CHU Toulouse, Hôpital Purpan, Toulouse, France
INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France
Search for more papers by this authorCatherine Patte
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorMarie-Cécile Le Deley
Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France
Univ Paris-Sud, Le Kremlin-Bicêtre, France
Search for more papers by this authorDominique Valteau-Couanet
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Search for more papers by this authorCorresponding Author
Laurence Brugières
Department of Paediatric Oncology, Institut Gustave Roussy, Villejuif, France
Correspondence: Dr Laurence Brugières, Department of Paediatric Oncology, Institut Gustave Roussy, 114 Rue Edouard-Vaillant, 94805 Villejuif Cedex, France.
E-mail: [email protected]
Search for more papers by this authorSummary
Haemophagocytic lymphohistiocytosis (HLH) has been rarely described in children treated for an anaplastic large-cell lymphoma (ALCL). We evaluated the incidence, the clinical and histological characteristics and the prognosis of HLH associated-ALCL. The medical, biological, cytological and histological data of patients treated for ALK-positive ALCL in the paediatric department of a single institution between 1975 and 2008 were analysed and assessed for HLH according to diagnosis criteria of the Histiocyte Society. Data concerning a series of 50 consecutive children with ALCL were reviewed. HLH-associated ALCL was observed in 12% of the patients. Lung involvement was significantly more frequent in HLH-associated ALCL patients than in the group without HLH (P = 0·004), as well as central nervous system (CNS) and bone marrow involvement (P = 0·001 and P = 0·007 respectively). The histological subtype in children with HLH-associated ALCL did not differ from that of the group without HLH. There was no significant difference between the two groups in 5-year EFS and OS (P = 0·91 and P > 0·99 respectively). In conclusion, HLH is not rare in paediatric ALCL. Despite a high incidence of visceral, CNS and bone marrow involvement, HLH does not seem to exert a significant impact on outcome in children treated for ALCL.
References
- Allory, Y., Challine, D., Haioun, C., Copie-Bergman, C., Delfau-Larue, M., Boucher, E., Charlotte, F., Fabre, M., Michel, M. & Gaulard, P. (2001) Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. American Journal of Surgical Pathology, 25, 865–874.
- Amin, H.M. & Lai, R. (2007) Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood, 110, 2259–2267.
- d'Amore, E.S., Menin, A., Bonoldi, E., Bevilacqua, P., Cazzavillan, S., Donofrio, V., Gambini, C., Forni, M., Gentile, A., Magro, G., Boldrini, R., Pillon, M., Rosolen, A. & Alaggio, R. (2007) Anaplastic large cell lymphomas: a study of 75 pediatric patients. Pediatric and Developmental Pathology, 10, 181–191.
- Balwierz, W., Czogala, M. & Czepko, E. (2010) Anaplastic large cell lymphoma associated with hemophagocytic lymphohistiocytosis: a case report and review of the literature. Przeglad Lekarski, 67, 436–438.
- Blatt, J., Weston, B., Belhorn, T., Hamrick, H. & Maia, D. (2002) Childhood non-Hodgkin lymphoma presenting as hemophagocytic syndrome. Pediatric Hematology and Oncology, 19, 45–49.
- Brugières, L., Deley, M.C., Pacquement, H., Meguerian-Bedoyan, Z., Terrier-Lacombe, M.J., Robert, A., Pondarré, C., Leverger, G., Devalck, C., Rodary, C., Delsol, G. & Hartmann, O. (1998) CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood, 92, 3591–3598.
- Brugières, L., Quartier, P., Le Deley, M.C., Pacquement, H., Perel, Y., Bergeron, C., Schmitt, C., Landmann, J., Patte, C., Terrier-Lacombe, M.J., Delsol, G. & Hartmann, O. (2000) Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children – a report from the French Society of Pediatric Oncology. Annals of Oncology, 11, 53–58.
- Cannella, S., Santoro, A., Bruno, G., Pillon, M., Mussolin, L., Mangili, G., Rosolen, A. & Aricò, M. (2007) Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer, 109, 2566–2571.
- Celkan, T., Berrak, S., Kazanci, E., Celkan, T., Berrak, S., Kazanci, E., Ozyürek, E., Unal, S., Uçar, C., Yilmaz, S. & Gürgey, A. (2009) Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey. The Turkish Journal of Pediatrics, 51, 207–213.
- Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C. & Aricó, M. (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood, 100, 2266–2267.
- Clementi, R., Locatelli, F., Dupré, L., Garaventa, A., Emmi, L., Bregni, M., Cefalo, G., Moretta, A., Danesino, C., Comis, M., Pession, A., Ramenghi, U., Maccario, R., Aricò, M. & Roncarolo, M.G. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood, 105, 4424–4428.
- Falini, B. & Martelli, M.P. (2009) Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. Haematologica, 94, 897–900.
- Feldmann, J., Le Deist, F., Ouachée-Chardin, M., Certain, S., Alexander, S., Quartier, P., Haddad, E., Wulffraat, N., Casanova, J.L., Blanche, S., Fischer, A. & de Saint Basile, G. (2002) Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. British Journal of Haematology, 117, 965–972.
- Göransdotter Ericson, K., Fadeel, B., Nilsson-Ardnor, S., Söderhäll, C., Samuelsson, A., Janka, G., Schneider, M., Gürgey, A., Yalman, N., Révész, T., Egeler, R., Jahnukainen, K., Storm-Mathiesen, I., Haraldsson, A., Poole, J., de Saint Basile, G., Nordenskjöld, M. & Henter, J. (2001) Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. American Journal of Human Genetics, 68, 590–597.
- Gualco, G., Chioato, L., Weiss, L.M., Harrington, W.J. Jr & Bacchi, C.E. (2009) Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children. American Journal of Clinical Pathology, 132, 28–33.
- Gupta, S. & Weitzman, S. (2010) Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Review of Clinical Immunology, 6, 137–154.
- Gupta, A., Tyrrell, P., Valani, R., Benseler, S., Weitzman, S. & Abdelhaleem, M. (2008) The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 51, 402–404.
- Han, A.R., Lee, H.R., Park, B.B., Hwang, I.G., Park, S., Lee, S.C., Kim, K., Lim, H.Y., Ko, Y.H., Kim, S.H. & Kim, W.S. (2007) Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Annals of Hematology, 86, 493–498.
- Henter, J.I., Horne, A., Arico, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J. & Janka, G. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124–131.
- Jaffe, E.S., Krenacs, L. & Raffeld, M. (1997) Classification of T-cell and NK-cell neoplasms based on the REAL classification. Annals of Oncology, 8(Suppl. 2): 17–24.
- Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H. & McClain, K.L. (2011) How I treat hemophagocytic lymphohistiocytosis. Blood, 118, 4041–52.
- Khor, T.S., Alessandri, A.J. & Jevon, G.P. (2010) Infant anaplastic large cell lymphoma with hemophagocytic syndrome. Pediatric and Developmental Pathology, 13, 72–76.
- Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 61–66.
- Krenova, Z., Sterba, J., Blatny, J., Kren, L. & Slany, J. (2007) A case of anaplastic large cell lymphoma-induced hemophagocytic lymphohistiocytosis in an adolescent female. Pediatric Blood & Cancer, 49, 1056.
- Lamant, L., McCarthy, K., d'Amore, E., Klapper, W., Nakagawa, A., Fraga, M., Maldyk, J., Simonitsch-Klupp, I., Oschlies, I., Delsol, G., Mauguen, A., Brugières, L. & Le Deley, M.C. (2011) Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. Journal of Clinical Oncology, 29, 4669–4676.
- Le Deley, M.C., Reiter, A., Williams, D., Delsol, G., Oschlies, I., McCarthy, K., Zimmermann, M. & Brugières, L., European Intergroup for Childhood Non-Hodgkin Lymphoma (2008) Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood, 111, 1560–1566.
- Mehta, P.A., Davies, S.M., Kumar, A., Devidas, M., Lee, S., Zamzow, T., Elliott, J., Villanueva, J., Pullen, J., Zewge, Y. & Filipovich, A., Children's Oncology Group (2006) Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia, 20, 1539–1541.
- Mellgren, K., Hedegaard, C.J., Schmiegelow, K. & Müller, K. (2012) Plasma cytokine profiles at diagnosis in pediatric patients with non-hodgkin lymphoma. Journal of Pediatric Hematology/Oncology, 34, 271–275.
- Molleran Lee, S., Villanueva, J., Sumegi, J., Zhang, K., Kogawa, K., Davis, J. & Filipovich, A.H. (2004) Characterization of diverse PRF1 mutations leading to decreased natural killer cell activity in North America families with hemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 41, 137–144.
- Pachlopnik Schmid, J., Côte, M., Ménager, M.M., Burgess, A., Nehme, N., Ménasché, G., Fischer, A. & de Saint Basile, G. (2010) Inherited defects in lymphocyte cytotoxic activity. Immunological Reviews, 235, 10–23.
- Peluso, M.J., Chia, D., Sheen, W., Hutchinson, C. & Barakat, L. (2012) Infectious mimicry complicates diagnosis in hemophagocytic syndrome caused by anaplastic large-cell lymphoma. Case Reports in Medicine, 2012, 968706.
10.1155/2012/968706 Google Scholar
- Richards, M.A. & Stansfeld, A.G. (1998) Updated Kiel classification. Lancet, 1, 937.
- Rothman, K.J. (1978) Estimation of confidence limits for the cumulative probability of survival in life table analysis. Journal of Chronic Diseases, 31, 557–560.
- Rouphael, N.G., Talati, N.J., Vaughan, C., Cunningham, K., Moreira, R. & Gould, C. (2007) Infections associated with haemophagocytic syndrome. The Lancet Infectious Diseases, 7, 814–822.
- Santoro, A., Cannella, S., Trizzino, A., Lo Nigro, L., Corsello, G. & Aricò, M. (2005) A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica, 90, 697–698.
- Savan, R., McFarland, A.P., Reynolds, D.A., Feigenbaum, L., Ramakrishnan, K., Karwan, M., Shirota, H., Klinman, D.M., Dunleavy, K., Pittaluga, S., Anderson, S.K., Donnelly, R.P., Wilson, W.H. & Young, H.A. (2011) A novel role for IL-22R1 as a driver of inflammation. Blood, 117, 575–584.
- Schemper, M. & Smith, T.L. (1996) A note on quantifying follow-up in studies of failure time. Controlled Clinical Trials, 17, 343–346.
- Sevilla, D.W., Choi, J.K. & Gong, J.Z. (2007) Mediastinal adenopathy, lung infiltrates, and hemophagocytosis: unusual manifestation of pediatric anaplastic large cell lymphoma: report of two cases. American Journal of Clinical Pathology, 127, 458–464.
- Shimada, A., Kato, M., Tamura, K., Hirato, J., Kanegane, H., Takechi, Y., Park, M.J., Sotomatsu, M., Hatakeyama, S. & Hayashi, Y. (2008) Hemophagocytic lymphohistiocytosis associated with uncontrolled inflammatory cytokinemia and chemokinemia was caused by systemic anaplastic large cell lymphoma: a case report and review of the literature. Journal of Pediatric Hematology/Oncology, 30, 785–787.
- Smyth, M.J., Thia, K.Y., Street, S.E., MacGregor, D., Godfrey, D.I. & Trapani, J.A. (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. Journal of Experimental Medicine, 192, 755–760.
- Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., Henter, J.I., Bennett, M., Fischer, A., de Saint Basile, G. & Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lympohystiocytosis. Science, 286, 1957–1959.
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987–994.
- Ueda, I., Morimoto, A., Inaba, T., Yagi, T., Hibi, S., Sugimoto, T., Sako, M., Yanai, F., Fukushima, T., Nakayama, M., Ishii, E. & Imashuku, S. (2003) Characteristic perforin gene mutations of hemophagocytic lymphohistiocytosis patients in Japan. British Journal of Haematology, 121, 503–510.
- Williams, D.M., Hobson, R., Imeson, J., Gerrard, M., McCarthy, K. & Pinkerton, C.R. (2002) Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. British Journal of Haematology, 117, 812–820.
- Xie, W., Hu, K., Xu, F., Zhou, D., He, J., Shi, J., Luo, Y., Zhu, J., Zhang, J., Lin, M., Ye, X., Huang, H. & Cai, Z. (2013) Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Annals of Hematology, 92, 481–486.
- Zur Stadt, U., Beutel, K., Weber, B., Kabisch, H., Schneppenheim, R. & Janka, G. (2004) A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood, 104, 1909.